• Leucovorin Calcium: Applied Protocols for Methotrexate Rescu

  2026-06-29

  Leucovorin Calcium (calcium folinate) is an advanced reagent for protecting cell cultures from methotrexate-induced toxicity and enhancing reproducibility in complex cancer models. Discover stepwise workflows, experimental optimizations, and troubleshooting tips rooted in the latest assembloid methodologies and antifolate resistance research.

• METTL17 Regulates Ferroptosis via Mitochondrial Translation

  2026-06-29

  This study reveals that the mitochondrial methyltransferase METTL17 promotes ferroptosis resistance and tumorigenesis in colorectal cancer by regulating mitochondrial RNA methylation and translation. Targeting METTL17 sensitizes cancer cells to ferroptosis, offering a promising therapeutic avenue for overcoming resistance in colorectal tumors.

• SAG Protects Neurons by Modulating Astrocyte Reactivity in F

  2026-06-28

  Vicente-Acosta et al. demonstrate that pharmacological activation of the Hedgehog signaling pathway with the Smoothened agonist SAG mitigates mitochondrial dysfunction and neurotoxicity in frataxin-deficient astrocytes, a central mechanism in Friedreich’s ataxia. Their findings highlight SAG's potential as a tool for dissecting neuron–glia interactions and developing neuroprotective strategies in neurodegenerative disease models.

• FPH1 (BRD-6125): Advancing Hepatocyte Proliferation Assays

  2026-06-27

  FPH1 (BRD-6125) sets a new standard for scalable, donor-independent hepatocyte expansion and functional maturation, critical for drug discovery and regenerative medicine. Discover how optimized protocols and integration with next-gen gene regulation unlock robust, reproducible primary human hepatocyte culture.

• Epoxomicin: Precision Proteasome Inhibitor for PQC Research

  2026-06-26

  Epoxomicin streamlines protein degradation assays with nanomolar selectivity, empowering advanced ubiquitin-proteasome pathway research and disease modeling. This guide delivers hands-on protocols, troubleshooting insights, and a practical translation of the latest ER stress findings to maximize assay performance.

• Optimizing Cell Assays with 5,6-Dichloro-1-β-D-ribofuranosyl

  2026-06-26

  This article explores the practical challenges and solutions in cell viability, proliferation, and cytotoxicity assays using 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (DRB, SKU C4798). Through five scenario-driven Q&A blocks, it highlights how DRB ensures reproducible inhibition of transcriptional elongation and cyclin-dependent kinase signaling, supporting sensitive and reliable data for biomedical researchers.

• AhR Antagonism Mitigates MEHP-Induced Ovarian Toxicity in Mi

  2026-06-25

  This study demonstrates that the aryl hydrocarbon receptor (AhR) mediates MEHP-induced impairment of follicle growth and estrogen production in mouse ovarian antral follicles. Using the AhR antagonist CH 223191, the authors provide direct evidence that blocking AhR signaling can partially rescue ovarian function, highlighting a mechanistic link between environmental phthalates and reproductive toxicity.

• Midecamycin: Mechanistic Insights and Advanced Assay Applica

  2026-06-25

  Explore the unique antibacterial mechanisms of Midecamycin, a potent acetoxy-substituted macrolide antibiotic, and discover advanced considerations for assay design and interpretation. This article delivers new perspectives and protocol guidance for researchers seeking reliable, high-sensitivity results.

• Targeted Non-Viral Gene Delivery to Adipocytes via ATS-9R

  2026-06-24

  Won et al. (2014) introduced ATS-9R, a non-viral fusion oligopeptide enabling selective gene delivery to mature adipocytes through Prohibitin-mediated endocytosis. This targeted approach supports efficient gene silencing with metabolic benefits, addressing longstanding challenges in obesity and metabolic research.

• Sisomicin vs. Kanamycin: In Vitro Activity Against Clinical

  2026-06-23

  The reference study rigorously compared the antimicrobial efficacy of sisomicin, a novel aminoglycoside, against a diverse set of clinical bacterial isolates. The findings highlight sisomicin’s superior in vitro activity relative to kanamycin and its close comparators, providing important context for antibiotic resistance research and guiding antibiotic selection protocols.

• Antimycin A4: ATP-Citrate Lyase Inhibition from Streptomyces

  2026-06-23

  The referenced study identifies Antimycin A4 and related compounds from Streptomyces sp. as a new class of ATP-citrate lyase inhibitors, expanding their established roles as antibiotics and mitochondrial inhibitors. These findings have significant implications for metabolic research, particularly in dissecting fatty acid and cholesterol biosynthesis.

• Strategic ALK Inhibition: LDN-193189 in Translational Resear

  2026-06-22

  Explore how LDN-193189, a selective ALK inhibitor, is reshaping BMP pathway research and translational strategies. This article provides mechanistic insights, protocol guidance, and a forward-looking perspective on epithelial plasticity and stem cell biology, integrating findings from the latest literature and highlighting new experimental approaches.

• Epigenetic Disruption and Translational Leverage with Thiogu

  2026-06-22

  This thought-leadership article explores the unique dual role of thioguanine (6-thioguanine) as both a DNA methyltransferase 1 (DNMT1) inhibitor and a cytotoxic agent, unpacking how its mechanistic features enable translational researchers to bridge cancer epigenetics, antiviral strategies, and immunomodulation. Drawing on recent evidence, including the pivotal role of miRNA methylation in acute lymphoblastic leukemia and best practices for experimental design, we outline a competitive, protocol-driven pathway for leveraging thioguanine in next-generation therapies.

• Solving Lab Challenges with V5 Epitope Tag Peptide (SKU A600

  2026-06-21

  This article addresses real-world experimental issues in protein detection and assay reproducibility, demonstrating how the V5 Epitope Tag Peptide (SKU A6005) offers validated solutions. By examining evidence-backed scenarios, it guides biomedical researchers and lab technicians in optimizing workflow specificity and reliability using APExBIO's high-purity peptide.

• METTL17 Modulates Ferroptosis Resistance in Colorectal Cance

  2026-06-20

  This study uncovers a novel mitochondrial defense mechanism in colorectal cancer, where METTL17 regulates ferroptosis resistance through control of mitochondrial RNA methylation and translation. Targeting METTL17 sensitizes tumor cells to ferroptosis, offering a promising therapeutic strategy for overcoming resistance in colorectal malignancies.

16154 records 1/1077 page Next 12345 下5页 Last page